Supplementary Information from Interplay Between V-ATPase G1 and Small EV-miRNAs Modulates ERK1/2 Activation in GBM Stem Cells and Nonneoplastic Milieu

Andrea Di Cristofori,Manuela Caroli,Dario C. Altieri,Irene Bertolini,Stefano Ferrero,Marco Locatelli,Alessandra Maria Storaci,Andrea Terrasi,Valentina Vaira

doi:10.1158/1541-7786.22514611.v1

Supplementary Information from Interplay Between V-ATPase G1 and Small EV-miRNAs Modulates ERK1/2 Activation in GBM Stem Cells and Nonneoplastic Milieu

Andrea Di Cristofori, Manuela Caroli + Show 7 more

Open Access

https://doi.org/10.1158/1541-7786.22514611.v1

Copy DOI

Publication Date: Apr 3, 2023

License type: CC BY 4.0

#Small EV #Small EVs + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

<p>Figure S1. Selection of optimal sEV concentration and Concanamycin A dose. Figure S2. Small EVs characterization. Figure S3. Functional effects of NS-derived small EVs. Figure S4. Bafilomycin A1 treatment in NS does not interfere with their ability to secrete small EVs. Figure S5. sEV-mediated modulation of cancer pathway in recipient cells. Figure S6. miRNA content in NS small EV.</p>

Full Text